Canadian Study Suggests Drug-Eluting Stents May Improve Long-Term Survival
This article was originally published in The Gray Sheet
Executive Summary
Drug-eluting stents may provide a long-term mortality benefit over bare-metal stents for at least some patients, according to a Canadian registry study in the Oct. 4 New England Journal of Medicine
You may also be interested in...
Drug-Eluting-Stent Market Penetration At Nadir? Rebound Forecast At TCT
U.S. drug-eluting-stent market penetration reached an all-time low in September, but clinicians meeting last week in Washington, D.C., are confident new data will help to reverse the trend that began just over a year ago
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.